S100A8/A9 has become a widespread biomarker used in the diagnosis and monitoring of inflammatory bowel disease (IBD) [7] and has been proposed as a potential biomarker for psoriasis and psoriasis arthritis (PsA) [8, 9]. Here, IGKV1D-22 is linked to inflammatory bowel disease.